LOS ANGELES CAPITAL MANAGEMENT LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 302 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$234,251
-51.2%
10,467
-40.0%
0.00%
-50.0%
Q1 2024$480,022
+34.6%
17,449
+49.2%
0.00%
+100.0%
Q4 2023$356,581
+0.0%
11,695
+3.7%
0.00%
-50.0%
Q3 2023$356,452
-20.4%
11,273
+2.7%
0.00%0.0%
Q2 2023$447,724
+21.3%
10,979
+10.9%
0.00%0.0%
Q1 2023$369,010
-0.8%
9,901
-7.1%
0.00%0.0%
Q4 2022$372,032
-44.3%
10,663
-10.7%
0.00%
-33.3%
Q3 2022$668,000
+21.2%
11,943
+12.2%
0.00%0.0%
Q2 2022$551,000
-23.3%
10,642
+7.8%
0.00%0.0%
Q1 2022$718,000
-44.4%
9,875
-9.6%
0.00%
-40.0%
Q4 2021$1,292,000
-12.6%
10,925
-0.9%
0.01%
-28.6%
Q3 2021$1,479,000
-7.9%
11,026
+11.1%
0.01%0.0%
Q2 2021$1,606,000
+90.3%
9,920
-5.7%
0.01%
+75.0%
Q1 2021$844,000
-41.6%
10,520
-60.4%
0.00%
-33.3%
Q4 2020$1,444,000
+167.4%
26,545
-2.2%
0.01%
+200.0%
Q3 2020$540,000
-4.6%
27,145
+0.8%
0.00%
-33.3%
Q2 2020$566,000
+69.5%
26,920
-1.3%
0.00%
+50.0%
Q1 2020$334,00027,2700.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders